Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to α1-acid glycoprotein

Biochemistry

Volumn 44, Issue 37, 2005, Pages 12384-12390

  Smolarczyk, Katarzyna ^a   Gils, Ann ^b   Boncela, Joanna ^a   Declerck, Paul J ^b   Cierniewski, Czeslaw S ^a,c  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; ANTIBODIES; BIOASSAY; CONFORMATIONS; MOLECULES; PROTEINS; SUBSTITUTION REACTIONS;

BINDING ASSAYS; BINDING DOMAIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ENZYME INHIBITION;

COMPLEMENTARY DNA; EPITOPE; MUTANT PROTEIN; OROSOMUCOID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; NUCLEOTIDE SEQUENCE; PLASMINOGEN ACTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; DNA PRIMERS; EPITOPES; KINETICS; MODELS, MOLECULAR; OROSOMUCOID; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS;

EID: 24944437070     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi050690p     Document Type: Article

References (36)

1. Fay, W. P., Shapiro, A. D., Shih, J. L., Schleef, R. R., and Ginsburg, D. (1992) Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation, N. Engl. J. Med. 327, 1729-1733.
2. Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., Van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., and Mulligan, R. C. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. 1. Generation by homologous recombination and characterization, J. Clin. Invest. 92, 2746-2755.
3. Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Paques, E. P., Preissner, K. T., Muller-Berghaus, G., and Collen, D. (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin), J. Biol. Chem. 263, 15454-15461.
4. Lawrence, D. A., Palaniappan, S., Stefansson, S., Olson, S. T., Francis-Chmura, A. M., Shore, J. D., and Ginsburg, D. (1997) Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis, J. Biol. Chem. 272, 7676-7680.
5. Deng, G., Royle, G., Wang, S., Crain, K., and Loskutoff, D. J. (1996) Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin, J. Biol. Chem. 271, 12716-12723.
6. Boncela, J., Papiewska, I., Fijałkowska, I., Walkowiak, B., and Cierniewski, C. S. (2001) Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity, J. Biol. Chem. 276, 35305-35311.
7. Fournier, T., Medjoubi, N., and Porquet, D. (2000) Alpha-1-acid glycoprotein, Biochim. Biophys. Acta 1482, 157-171.
8. Kushner, I. (1982) The phenomenon of the acute phase response, Ann. N.Y. Acad. Sci. 389, 39-49.
9. Sorensson, J., Matejka, G. L., Ohlson, M., and Haraldsson, B. (1999) Human endothelial cells produce orosomucoid, an important component of the capillary barier, Am. J. Physiol. 276, H530-H534.
10. Shibata, Y., Tamura, K., and Ishida, N. (1984) Cultured human monocytes, granulocytes and a monoblastoid cell line (THP-1) synthesize and secrete immunosuppressive acidic protein (a type of alpha 1-acid glycoprotein), Microbiol. Immunol. 28, 99-111.
11. 1-acid glycoprotein, in The Plasma Proteins, Structure, Function and Genetic Control (Putnam, F. W., Ed.) pp 183-228, Academic Press, New York.
12. Fey, G. H., and Fuller, G. M. (1987) Regulation of acute phase gene expression by inflammatory mediators, Mol. Biol. Med. 4, 323-338.
13. Williams, J. P., Weiser, M. R., Pechet, T. T., Kobzik, L., Moore, F. D., and Hechtman, H. B., Jr. (1997) alpha 1-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat, Am. J. Physiol. 273, G1031-G1035.
14. Haraldsson, B., and Rippe, B. (1987) Orosomucoid as one of the serum components contributing to normal capillary permselectivity in rat skeletal muscle, Acta Physiol. Scand. 129, 127-135.
15. Haraldsson, B. S., Johnsson, E. K., and Rippe, B. (1992) Glomerular permselectivity is dependent on adequate serum concentrations of orosomucoid, Kidney Int. 41, 310-316.
16. Gabay, C., and Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation, N. Engl. J. Med. 340, 448-454.
17. Gils, A., Knockaert, I., and Declerck, P. J. (1996) Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop, Biochemistry 35, 7474-7481.
18. Bijnens, A. P., Gils, A., Knockaert, I., Stassen, J. M., and Declerck, P. J. (2000) Importance of the hinge region between α-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies, J. Biol. Chem. 275, 6375-6380.
19. Declerck, P. J., De Mol, M., Vaughan, D. E., and Collen, D. (1992) Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator, J. Biol. Chem. 267, 11693-11696.
20. Debrock, S., and Declerck, P. J. (1997) Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms, Biochim. Biophys. Acta 1337, 257-266.
21. Ey, P. L., Prowse, S. J., and Jenkins, C. R. (1978) Isolation of pure IgGl, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose, Immunochemistry 15, 429-436.
22. Sprengers, E. D., Akerman, J. W. W., and Jansen, B. G. (1986) Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blond, Thromb. Haemostasis 55, 325-329.
23. Pannekoek, H., Veerman, H., Lambers, H., Diergaarde, P., Verweij, C., van Zonneveld, A., and Van Mourik, J. (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family, EMBO J. 5, 2539-2544.
24. Lindahl, T. L., Sigurdardottir, O., and Wiman, B. (1989) Stability of plasminogen activator inhibitor 1 (PAI-1), Thromb. Haemostasis 62, 748-751.
25. Komissarov, A. A., Declerck, P. J., and Shore, J. D. (2002) Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies, J. Biol. Chem. 277, 43858-43865.
26. Bijnens, A. P., Gils, A., Stassen, J. M., Komissarov, A. A., Knockaert, I., Brouwers, E., Shore, J. D., and Declerck, P. J. (2001) The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activity, J. Biol. Chem. 276, 44912-44918.
27. Ngo, T. H., Debrock, S., and Declerck, P. J. (1997) Identification of functional synergism between monoclonal antibodies. Application to the enhancement of plasminogen activator inhibitor-1 neutralizing effects, FEBS Lett. 416, 373-376.
28. Verhamme, I., Kvassman, J. O., Day, D., Debrock, S., Vleugels, N., Declerck, P. J., and Shore, J. D. (1999) Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding, J. Biol. Chem. 274, 17511-17517.
29. Bijnens, A. P., Ngo, T. H., Gils, A., Dewaele, J., Knockaert, I., Stassen, J. M., and Declerck P. J. (2001) Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1, Thromb. Haemostasis 85, 866-874.
30. Gorlatova, N. V., Elokdah, H., Fan, K., Crandall, D. L., and Lawrence, D. A. (2003) Mapping of a conformational epitope on plasminogen activator inhibitor-1 by random mutagenesis. Implications forserpin function, J. Biol. Chem. 278, 16329-16335.
31. Naessens, D., Gils, A., Compernolle, G., and Declerck, P. J. (2003) Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibition, Thromb Haemostasis 90, 52-58.
32. Debrock, S., and Declerck, P. J. (1998) Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop, Thromb. Haemostasis 79, 597-601.
33. Zhou, A., Huntington, J. A., Pannu, N. S., Carrell, R. W., and Read, R. J. (2003) How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration, Nat. Struct. Biol. 10, 541-544.
34. Lawrence, D. A., Berkenpas, M. B., Palaniappan, S., and Ginsburg, D. (1994) Localization of vitronectin binding domain in plasminogen activator inhibitor-1, J. Biol. Chem. 269, 15223-15228.
35. Jensen, J. K., Wind, T., and Andreasen, P. A. (2002) The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand, FEBS Lett. 521, 91-94.
36. Jensen, J. K., Durand, M. K., Skeldal, S., Dupont, D. M., Bodker, J. S., Wind, T., and Andreasen, P. A. (2004) Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal, FEBS Lett. 556, 175-179.